Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
Yoo C, Yun MR, Ahn JH, Jung KH, Kim HJ, Kim JE, Park JY, Park KO, Yoon DH, Kim SB. Yoo C, et al. Among authors: kim sb, kim hj, kim je. Cancer Chemother Pharmacol. 2013 Sep;72(3):565-75. doi: 10.1007/s00280-013-2227-5. Epub 2013 Jul 11. Cancer Chemother Pharmacol. 2013. PMID: 23842722 Clinical Trial.
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers.
Park JH, Kang MJ, Ahn JH, Kim JE, Jung KH, Gong G, Lee HJ, Son BH, Ahn SH, Kim HH, Shin HJ, Moon DH, Kim SB. Park JH, et al. Among authors: kim sb, kim hh, kim je. Cancer Chemother Pharmacol. 2016 Oct;78(4):685-95. doi: 10.1007/s00280-016-3107-6. Epub 2016 Aug 4. Cancer Chemother Pharmacol. 2016. PMID: 27491481 Clinical Trial.
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
Park JH, Lee JS, Koo H, Kim JE, Ahn JH, Ryu MH, Park SR, Yoon SK, Lee JC, Hong YS, Kim SY, Kim KP, Yoo CH, Hong JY, Lee JL, Jung KH, Rhyoo BY, Kim TW. Park JH, et al. Among authors: kim tw, kim kp, kim sy, kim je. J Cancer Educ. 2020 Jun;35(3):545-556. doi: 10.1007/s13187-019-01494-6. J Cancer Educ. 2020. PMID: 30820925
3'-Deoxy-3'-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies.
Kim JE, Chae SY, Kim JH, Kim HJ, Kim TW, Kim KP, Kim SY, Lee JL, Oh SJ, Kim JS, Ryu JS, Moon DH, Hong YS. Kim JE, et al. Among authors: kim hj, kim tw, kim kp, kim sy, kim js, kim jh. Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1713-1722. doi: 10.1007/s00259-019-04330-7. Epub 2019 Apr 30. Eur J Nucl Med Mol Imaging. 2019. PMID: 31041456
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study.
Kim JH, Kim SY, Kim KP, Kim TW, Chae SY, Kim HJ, Kim JS, Ryu JS, Moon DH, Kim JE, Hong YS. Kim JH, et al. Among authors: kim hj, kim tw, kim kp, kim sy, kim js, kim je. Target Oncol. 2019 Dec;14(6):689-697. doi: 10.1007/s11523-019-00672-2. Target Oncol. 2019. PMID: 31555963
4,292 results